A cannabis producer that has a large-scale greenhouse operation in East Ladner is getting into the United Kingdom market.
AgraFlora Organics International Inc., which has a partnership with the huge Houweling Nurseries complex on 64th Street, a 2.2-million-square-foot facility called the Delta Greenhouse Complex, has announced that a subsidiary called Farmako Ltd. has received its Home Office Controlled Drug Licence in the UK.
Farmako was awarded the Licence less than one month following the successful completion of its inspection by the UK Home Office in December 2019, a news release states.
Farmako intends to commence wholesaling medical cannabis in the UK by mid-year 2020, including the importation of Bedrocan products from the Netherlands to the UK for patient distribution.
“The UK medicinal cannabis market has been estimated to reach US $1.3 billion by 2024, with up to one per cent of the UK’s population expected to be eligible to receive medicinal cannabis prescriptions by 2021,” said Katrin Eckmans, CEO of Farmako.
“Obtaining the licence is a key milestone for our European business, positioning Farmako Ltd. as an early leader in the rapidly developing UK medicinal cannabis market.”
The UK cannabis market is still in its early stages with recent legislative changes allowing specialist physicians to prescribe medical fulfilled through a pharmacy model, AgraFlora explains.
In addition, UK medical cannabis patients benefit from broad insurance coverage for medical cannabis provided by the UK’s National Health Service.
In addition to its Delta greenhouse, AgraFlora owns an indoor cultivation operation in London, Ontario and is a joint venture partner in Propagation Services Canada Inc.
The company is also retrofitting a 51,500-square-foot good manufacturing practice edibles manufacturing facility in Winnipeg.